1-2 of 2
Tim Wert
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Understanding What Matters to Myelodysplastic Syndrome Patients - a Study of Preferences for Treatments with Hypomethylating Agents

Amer M. Zeidan, Sophie (jui-Hua) Tsai, Milad Karimi, Jordana Schmier, Sayeli Jayade, Evangelos Zormpas, Audrey Hassan, Desiree Ruiters, Cindy Anthony, Kala Hill, Tim Wert, Marc Botteman
Journal: Blood
Blood (2022) 140 (Supplement 1): 10847–10848.
https://doi.org/10.1182/blood-2022-167360
Published: 2022
Journal Articles

The Direct Medical Costs of Treatment Discontinuation Among Higher-Risk Myelodysplastic Syndrome Patients Receiving Hypomethylating Agents

Namita Joshi, PhD MS, BPharm, Hrishikesh P Kale, PhDMS,BPharm, Shelby Corman, PharmD, MS, BCPS, Kala Hill, Tim Wert, Amer M. Zeidan, MBBS, MHS
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-139642
Published: 2020